PRLD

NASD Prelude Therapeutics, Inc.
Sep 30, 2026 · 5:56 AM ET EOD Market Closed

$3.96 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.96, $0.04 below the day’s high of $4.00

YTD change
+36.55%
vs 20-day SMA
-17.10%
vs 200-day SMA
+3.05%

Price ranges

Previous day
$3.83 $4.00
open $3.95 close $3.96
+$0.01 (+0.25%)
Today
$3.83 $4.00
$3.96
Past week
$3.72 $4.91
from $4.70 now $3.96
-$0.74 (-15.74%)
Past month
$3.72 $5.82
from $5.47 now $3.96
-$1.51 (-27.61%)
This year
$1.77 $6.83
from $2.90 now $3.96
+$1.06 (+36.55%)

Price & Performance

+0.89 (+28.99%) / 6M

$2.79$4.16$5.54$6.91Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 95.8% away from all-time highs of $95.38
  • PRLD is up 37% since the beginning of the year
  • PRLD is up 189% over the past 12 months
  • PRLD is down 28% over the past 1 month
  • 8% of all PRLD investors are betting against PRLD

PRLD reads neutral: price sits above one of the two key moving averages, the 12-month move is +175.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.14
Earnings momentum +3600.0% Quarterly EPS growth
Quarterly change +3600.0%

Valuation

P/E ratio N/A
Enterprise value $250.6M
Beta 2.39

Balance sheet & scale

IncomeN/A
Revenue$22.4M
Cash$151.8M
Debt$17.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $329.7M

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.